Head of US Marketing, DDR
At AstraZeneca we’re dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There’s no better place to make a difference to medicine, patients and society
A dedicated Oncology unit, this is the place to build a world-class career Be part of fulfilling our ambition to be world leaders in Oncology. We are already the fastest growing team within AstraZeneca and across the industry, and there are countless new indications and targets in our game-changing pipeline. In our dynamic environment, be supported by the brightest minds working together side by side. Agile and collaborative, we work cross-functionally, as well as externally, to thrive at pace. We’ve created a culture where everybody, from all backgrounds, can be themselves and bring their true self to work. Speak up, step up and change the game for Oncology, now and in the future.
The Head of US Marketing, DDR (DNA Damage Response), is accountable for all DDR and DDR combination indications in the US and leads a team of marketers and cross-functional collaborators to develop and implement a robust commercial strategy for current and future DDR, a key target in the AstraZeneca oncology portfolio. You will own the strategic marketing of brand across current 8 indication across 4 tumors and build for the future with indication in new tumor areas. You will collaborate effectively with key partners including colleagues from the Global, Sales, Medical, Diagnostics, Commercial Operations, Managed Markets, and Corporate Affairs. You will also work closely with our Alliance partner to co-develop strategy and execution plans of current indications and partner across other AZ marketing teams for future combination indications Additionally, you will be a key member of the DDR franchise leadership team, the deputy for the franchise head and play a meaningful role in crafting the overall strategy and culture of the franchise.
Lead the commercial marketing strategy and execution for the franchise for current, future indications and future pipeline.
Lead the development of overarching HCP and consumer marketing strategies and tactics, the creation of brand strategy plans, launch plans, and competitive readiness plans.
Monitor and diagnose brand performance and lead business updates to senior leadership.
Lead partnership efforts to define lifecycle priorities, inform US labeling recommendations and share findings across markets.
Lead quarterly and annual US forecasting work for DDR, in conjunction with the Insights and Finance teams; develop quarterly performance updates in preparation for Earnings releases.
Develop and deliver key brand presentations to leadership and the DDR field organization.
Manage, coach, and develop a team of more than +20 employees.
Bachelor's Degree in relevant field
10 years of pharmaceutical or related experience in oncology marketing (US oncology pharmaceutical marketing experience strongly preferred)
People leadership experience
Exhibit high capability at working collaboratively, thinking strategically
Comprehensive understanding of drug development and commercialization process
Proven competency in marketing, both HCP, and Consumer
Deep experience in US pharmaceutical marketing in Oncology
Experience leading an Oncology Marketing Team
Customer-facing Oncology Experience
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.